Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease

Case Reports

Masahiko Shimura et al. Br J Ophthalmol. 2010 Mar.

. 2010 Mar;94(3):381-3.

doi: 10.1136/bjo.2009.160986.

No abstract available

Comment on

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.
Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, Schmidt-Erfurth U. Kriechbaum K, et al. Br J Ophthalmol. 2008 Apr;92(4):518-22. doi: 10.1136/bjo.2007.127282. Epub 2008 Jan 22. Br J Ophthalmol. 2008. PMID: 18211942 Clinical Trial.
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.
Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U. Prager F, et al. Br J Ophthalmol. 2009 Apr;93(4):452-6. doi: 10.1136/bjo.2008.141085. Epub 2008 Dec 15. Br J Ophthalmol. 2009. PMID: 19074916 Clinical Trial.